4.8 Article

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

期刊

CELL
卷 181, 期 5, 页码 1036-+

出版社

CELL PRESS
DOI: 10.1016/j.cell.2020.04.026

关键词

-

资金

  1. Marc Haas Foundation
  2. National Institutes of Health [5U19AI111825-07, 5R01AI139119-02, R01DK121072, R01AIAI145882, R01AI110575, R21AI149033]
  3. DARPA's PREPARE Program [HR0011-20-2-0040]
  4. Stanford University
  5. Searle Scholars Program
  6. CRIP (Center for Research on Influenza Pathogenesis), a NIAID [HHSN272201400008C]
  7. USPHS [T32-AI07647]
  8. NIH [R01 AI123155]

向作者/读者索取更多资源

Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. Wepropose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据